JP2010521519A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010521519A5 JP2010521519A5 JP2009554033A JP2009554033A JP2010521519A5 JP 2010521519 A5 JP2010521519 A5 JP 2010521519A5 JP 2009554033 A JP2009554033 A JP 2009554033A JP 2009554033 A JP2009554033 A JP 2009554033A JP 2010521519 A5 JP2010521519 A5 JP 2010521519A5
- Authority
- JP
- Japan
- Prior art keywords
- testosterone
- boy
- treatment
- adolescent
- age
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 claims 46
- 229960003604 testosterone Drugs 0.000 claims 23
- 210000002966 serum Anatomy 0.000 claims 7
- 239000000499 gel Substances 0.000 claims 5
- 239000012049 topical pharmaceutical composition Substances 0.000 claims 5
- 206010012559 Developmental delay Diseases 0.000 claims 3
- 206010058359 Hypogonadism Diseases 0.000 claims 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 230000002381 testicular Effects 0.000 claims 2
- 239000003349 gelling agent Substances 0.000 claims 1
- 239000003961 penetration enhancing agent Substances 0.000 claims 1
- 239000008213 purified water Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07104726 | 2007-03-23 | ||
| PCT/EP2008/053372 WO2008116825A2 (en) | 2007-03-23 | 2008-03-20 | Compositions and method for treating pediatric hypogonadism |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010521519A JP2010521519A (ja) | 2010-06-24 |
| JP2010521519A5 true JP2010521519A5 (enExample) | 2011-05-06 |
Family
ID=38321980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009554033A Pending JP2010521519A (ja) | 2007-03-23 | 2008-03-20 | 小児性腺機能低下症の治療用組成物及び治療方法 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2136813A2 (enExample) |
| JP (1) | JP2010521519A (enExample) |
| CN (1) | CN101754764A (enExample) |
| AU (1) | AU2008231781B2 (enExample) |
| BR (1) | BRPI0809124A8 (enExample) |
| CA (1) | CA2623477C (enExample) |
| EA (1) | EA018775B1 (enExample) |
| IL (1) | IL200887A0 (enExample) |
| MX (1) | MX2009008995A (enExample) |
| WO (1) | WO2008116825A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3755B1 (ar) * | 2011-01-26 | 2021-01-31 | Ferring Bv | تركيبات تستوستيرون |
| MX395212B (es) * | 2011-05-15 | 2025-03-21 | Acerus Biopharma Inc | Geles nasales de liberación controlada de testosterona, métodos y sistemas aplicadores multidosis pre cargados para administración pernasal. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6503894B1 (en) * | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| US20030139384A1 (en) * | 2000-08-30 | 2003-07-24 | Dudley Robert E. | Method for treating erectile dysfunction and increasing libido in men |
| US20040072810A1 (en) * | 2001-11-07 | 2004-04-15 | Besins International Belgique | Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof |
| US7138389B2 (en) * | 2004-02-09 | 2006-11-21 | University Of Washington | Oral androgen therapy using modulators of testosterone bioavailability |
| SI1937276T1 (sl) * | 2005-10-12 | 2013-04-30 | Unimed Pharmaceuticals, Llc C/O Abbott Laboratoires 100 Abbott Park Road | Izboljšani testosteronski gel in postopek uporabe |
-
2008
- 2008-03-20 WO PCT/EP2008/053372 patent/WO2008116825A2/en not_active Ceased
- 2008-03-20 CA CA2623477A patent/CA2623477C/en active Active
- 2008-03-20 JP JP2009554033A patent/JP2010521519A/ja active Pending
- 2008-03-20 AU AU2008231781A patent/AU2008231781B2/en active Active
- 2008-03-20 MX MX2009008995A patent/MX2009008995A/es not_active Application Discontinuation
- 2008-03-20 CN CN200880009284A patent/CN101754764A/zh active Pending
- 2008-03-20 BR BRPI0809124A patent/BRPI0809124A8/pt not_active Application Discontinuation
- 2008-03-20 EA EA200901288A patent/EA018775B1/ru unknown
- 2008-03-20 EP EP08718089A patent/EP2136813A2/en not_active Withdrawn
-
2009
- 2009-09-13 IL IL200887A patent/IL200887A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE511847T1 (de) | Pharmazeutische zubereitung für die behandlung entzündlicher erkrankungen des urogenitaltraktes | |
| RU2350333C3 (ru) | Применение ивермектина для лечения дерматологических расстройств | |
| NZ609719A (en) | Pharmaceutical composition | |
| EP2671584A3 (en) | Compositions and methods for treating disorders associated with salt or fluid retention | |
| EA201490876A1 (ru) | Ингибиторы рециклинга желчных кислот при лечении холестатических заболеваний печени у детей | |
| AR063201A1 (es) | Composiciones farmaceuticas de ropinirol y metodos de uso de las mismas | |
| MX2011010347A (es) | Derivados sustituidos de azoantraceno, composiciones farmaceuticas y metodos de uso de los mismos. | |
| EA200800064A1 (ru) | Композиция в виде гранул с модифицированным и немедленным высвобождением мемантина | |
| MX2010004613A (es) | Composicion topica. | |
| JP2013526620A5 (enExample) | ||
| EA201170117A1 (ru) | Противоаллергические биополимеры морского происхождения | |
| JP2010520246A5 (enExample) | ||
| JP2011026348A5 (enExample) | ||
| WO2009004995A1 (ja) | 生理活性物質を定着および発現させる方法 | |
| HRP20211817T1 (hr) | Postupak adjuvantnog liječenja raka | |
| BR112015019776A2 (pt) | comprimidos de duplo uso oral em composições farmacêuticas de sais de sulfato e métodos de uso dos comprimidos | |
| MX2007008141A (es) | Composicion farmaceutica de sustancias labiles en medio acido. | |
| EP2251016A3 (en) | Topical use of hyaluronic acid with folmogenic action for the treatment and prophylaxys of pathologies of the respiratory tract. | |
| WO2009041111A1 (ja) | 経口投与剤 | |
| WO2007064968A3 (en) | Stable pharmaceutical compositions of 5,10 methylenetetrahydrofolate | |
| JP2009522376A5 (enExample) | ||
| EP1905426A3 (en) | Anti-acid pharmaceutical composition in powder form; pharmaceutical preparation containing it and process for making it | |
| RU2007101538A (ru) | Применение фармацевтической композиции, содержащей кальцитриол и пропионат клобетазола, для лечения псориаза | |
| CN102988277A (zh) | 一种治疗皮肤疣、甲真菌病和胼胝等皮肤病的油膏 | |
| CA3168207A1 (en) | Cellular uptake |